Page last updated: 2024-12-04

methacholine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methacholine : A quaternary ammonium ion in which the nitrogen is substituted with three methyl groups and a 2-acetoxypropyl group. Parasympathomimetic bronchoconstrictor drug used in clinical diagnosis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1993
CHEMBL ID978
CHEBI ID6804
SCHEMBL ID69103
MeSH IDM0024755

Synonyms (54)

Synonym
methacholinum
methacholin
brn 1769932
1-propanaminium, 2-(acetyloxy)-n,n,n-trimethyl-
choline, acetyl-beta-methyl-
mecholin
mecholine
ammonium, (2-hydroxypropyl)trimethyl-, acetate (ester)
beta-methylacetylcholine
CHEBI:6804 ,
acetylmethylcholine
2-acetyloxy-n,n,n-trimethylpropan-1-aminium
BSPBIO_000778
PRESTWICK2_000759
BPBIO1_000856
PRESTWICK3_000759
C07471
methacholine
acetyl-beta-methylcholine
55-92-5
LOPAC0_000025
BSPBIO_001985
SPBIO_002717
PRESTWICK1_000759
PRESTWICK0_000759
PDSP1_000136
PDSP2_000135
NCGC00089798-02
NCGC00015045-06
DB06709
CHEMBL978
methacholine cation
methacholine ion
03v657zd3v ,
unii-03v657zd3v
CCG-204121
NCGC00015045-04
NCGC00015045-03
gtpl7438
2-acetyloxypropyl-trimethylazanium
1-propanaminium, 2-(acetyloxy)-n,n,n-trimethyl-, (+/-)-
methacholine [who-dd]
methacholine [vandf]
SCHEMBL69103
DTXSID2046967
2-acetyloxypropyl(trimethyl)ammonium;chloride
cid_6114
bdbm48918
2-acetoxypropyl(trimethyl)ammonium;chloride
[2-(acetyloxy)propyl]trimethylazanium
SBI-0050014.P003
Q413188
NCGC00015045-13
mch; mecholin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
muscarinic agonistAny drug that binds to and activates a muscarinic cholinergic receptor.
bronchoconstrictor agentA drug which causes a narrowing of the lumen of a bronchus or bronchiole.
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
cholinergic agonistAny drug that binds to and activates cholinergic receptors.
vasodilator agentA drug used to cause dilation of the blood vessels.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
quaternary ammonium ionA derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLS proteinHomo sapiens (human)Potency2.81840.35487.935539.8107AID624146
regulator of G-protein signaling 4Homo sapiens (human)Potency0.84370.531815.435837.6858AID504845
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.98110.035520.977089.1251AID504332
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency42.56150.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Muscarinic acetylcholine receptor M2Homo sapiens (human)IC50 (µMol)2.79000.00001.23267.7930AID142395; AID142396
Muscarinic acetylcholine receptor M2Homo sapiens (human)Ki0.05900.00000.690210.0000AID142529
Muscarinic acetylcholine receptor M4Homo sapiens (human)Ki1.60000.00000.79519.1201AID141885
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)IC50 (µMol)0.70000.00052.747825.1700AID142006
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)Ki1.60000.00010.68688.2600AID142014
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)IC50 (µMol)3.59330.00053.314249.5000AID142809; AID142810
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.05900.00010.58908.2600AID142958
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NPYLR7BAedes aegypti (yellow fever mosquito)EC50 (µMol)20.00000.03902.289918.3000AID1259426
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)EC50 (µMol)0.40000.00001.262610.0000AID141447
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)EC50 (µMol)0.12000.00000.764610.0000AID141604
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of heart contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
response to virusMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M2Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M4Homo sapiens (human)
cell surface receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M4Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
arrestin family protein bindingMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
clathrin-coated endocytic vesicle membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
asymmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
symmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
neuronal cell bodyMuscarinic acetylcholine receptor M2Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M2Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M4Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (42)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID142396Inhibitory activity against [3H]quinuclidinyl Benzilate binding to Muscarinic acetylcholine receptor M2 in the presence of GTP1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID1132788Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 1 ug/ml1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Piperazinylpyrazines with central serotoninmimetic activity.
AID142006Inhibitory activity against [3H]-cyclic AMP accumulation in CHO transfected cells mediated by Muscarinic acetylcholine receptor M41998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID141458Percentage inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M31998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID141059Percentage inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M11998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID141578Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M1 in rat cerebral cortical membranes at 300 uM concentration1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID256509Agonistic activity against Sphingosine 1-phosphate receptor2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
AID256404Percent increase in airway resistance in anesthetized rats upon i.v. dose of 30 ug/kg/min over 30 min2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
AID141885Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M41998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142958Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M2 in rat cerebral cortical membranes1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142529Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M21998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID141607Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M3 in rat cerebral cortical membranes at 100 uM concentration1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142810Inhibition of binding of 0.1 nM [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M2 in rat cerebral cortical membranes of transfected CHO cells in the presence of 10 uM GTP1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142809Inhibition of binding of 0.1 nM [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M2 in rat cerebral cortical membranes of transfected CHO cells in the absence of GTP1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142014Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M4 in rat cerebral cortical membranes1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID141604Inhibitory activity against stimulation of [3H]inositol monophosphate accumulation in [3H]inositol-labelled CHO transfected cells mediated by Muscarinic acetylcholine receptor M31998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID142395Inhibitory activity against [3H]quinuclidinyl Benzilate binding to Muscarinic acetylcholine receptor M2 in the absence of GTP1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID141447Inhibitory activity against stimulation of [3H]inositol monophosphate accumulation in [3H]inositol-labelled CHO transfected cells mediated by Muscarinic acetylcholine receptor M11998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID1345699Rat M3 receptor (Acetylcholine receptors (muscarinic))1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID1345189Rat M1 receptor (Acetylcholine receptors (muscarinic))1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID1345435Rat M4 receptor (Acetylcholine receptors (muscarinic))1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
AID1345364Rat M2 receptor (Acetylcholine receptors (muscarinic))1998Journal of medicinal chemistry, Jun-04, Volume: 41, Issue:12
6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's1 (6.67)18.2507
2000's3 (20.00)29.6817
2010's5 (33.33)24.3611
2020's5 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 77.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index77.39 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index128.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (77.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]